Jazz Pharmaceuticals Plc (JAZZ) Files Form 4 Insider Selling : Michael Patrick Miller Sells 100 Shares

Jazz Pharmaceuticals Plc (JAZZ): Michael Patrick Miller , SVP, US Commercial of Jazz Pharmaceuticals Plc sold 100 shares on May 16, 2016. The Insider selling transaction was reported by the company on May 17, 2016 to the Securities and Exchange Commission. The shares were sold at $145.20 per share for a total value of $14,520.00 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on May 17, 2016, Heather Ann Mcsharry (director) sold 697 shares at $145.20 per share price.On May 17, 2016, Norbert G Riedel (director) sold 644 shares at $145.20 per share price.Also, On Apr 27, 2016, Karen J Wilson (SVP, Finance & PAO) sold 604 shares at $160.00 per share price.On Apr 18, 2016, Michael Patrick Miller (SVP, US Commercial) sold 100 shares at $145.79 per share price.

Jazz Pharmaceuticals plc – Ordinary Shares: On Monday, May 16, 2016 heightened volatility was witnessed in Jazz Pharmaceuticals plc – Ordinary Shares which led to swings in the share price. The shares opened for trading at $145.2 and hit $149.34 on the upside , eventually ending the session at $148.96, with a gain of 2.27% or 3.3 points. The heightened volatility saw the trading volume jump to 10,85,072 shares. The 52-week high of the share price is $194.73 and the company has a market cap of $9,000 M . The 52-week low of the share price is at $108.5.

Jazz Pharmaceuticals plc - Ordinary Shares Money Flow Index Chart

Company has been under the radar of several Street Analysts.Jazz Pharmaceuticals plc – Ordinary Shares is Upgraded by Mizuho to Buy and the brokerage firm has raised the Price Target to $ 193 from a previous price target of $137 .Earlier the firm had a rating of Neutral on the company shares. The Rating was issued on May 11, 2016.Jazz Pharmaceuticals plc – Ordinary Shares is Reiterated by UBS to Buy and the brokerage firm has raised the Price Target to $ 168 from a previous price target of $162 .The Rating was issued on May 11, 2016.Jazz Pharmaceuticals plc – Ordinary Shares is Upgraded by Sun Trust Rbsn Humphrey to Buy. Earlier the firm had a rating of Neutral on the company shares. The Rating was issued on Apr 25, 2016.Jazz Pharmaceuticals plc – Ordinary Shares is Reiterated by Mizuho to Neutral while Lowering the Price Target of the company shares to $ 124 from a previous price target of $140 . The Rating was issued on Feb 24, 2016.Jazz Pharmaceuticals plc – Ordinary Shares is Initiated by Wells Fargo to Outperform. The Rating was issued on Feb 19, 2016.

Leave a Reply

Jazz Pharmaceuticals plc - Ordinary Shares - Is it time to Sell?

Top Brokerage Firms are advising their investors on Jazz Pharmaceuticals plc - Ordinary Shares. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.